122
Views
1
CrossRef citations to date
0
Altmetric
CASE REPORT

Chalazion surgery: Advantages of a subconjunctival approach

, , , &
Pages 154-156 | Received 01 Feb 2009, Accepted 17 Mar 2009, Published online: 01 Sep 2009

References

  • Carter SR. Eyelid disorders: diagnosis and management. Am Fam Physician. 1998; 57: 997–1002.
  • Papier A, Tuttle DJ, Mahar TJ. Differential diagnosis of the swollen red eyelid. Am Fam Physician. 2007; 76: 1815–24.
  • Cahill KV, Burns JA. Benign eyelid lesions. J Dermatol Surg Oncol. 1992; 18: 1051–5.
  • Perry HD, Serniuk RA. Conservative treatment of chalazia. Ophthalmology. 1980; 87: 218–21.
  • Mohan K, Dhir SP, Munjal VP, Jain IS. The use of intralesional steroids in the treatment of chalazion. Ann Ophthalmol. 1996; 18: 158–60.
  • Goawalla A, Lee V. A prospective randomized treatment study comparing three treatment options for chalazia: triamcinolone acetonide injections, incision and curettage and treatment with hot compresses. Clin Experiment Ophthalmol. 2007; 35: 706–12.
  • Rawlings NG, Brownstein S, Jordan DR. Merkel cell carcinoma masquerading as a chalazion. Can J Ophthalmol. 2007; 42: 469–70.
  • Reifler DM, Leder DR. Eyelid crease approach for chalazion excision. Ophthal Plast Reconstr Surg. 1989; 5: 63–7.
  • Prasad S, Gupta AK. Subconjunctival total excision in the treatment of chronic chalazia. Indian J Ophthalmol. 1992; 40: 103–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.